Patent Yard Sign in
Canadian application, no grantCanada

Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor

CA 2477265 A1 · Owner: Hamelin, Estelle · Inventors: Quattropani, Anna; Schwarz, Matthias; Jorand-Lebrun, Catherine

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention is related to thiazolidine carboxamide derivatives of formula (II) for the treatment and/or prophylaxis of preterm labor premature , birth, dysmenorrhea and for stopping labor prior to cesarean delivery. G is selected from the group consisting of C1-C6-alkyl aryl C1-C6-alkyl , heteroaryl, C1-C6 Alkyl cycloalkyl C1-C6-alkyl heteroaryl, aryl, heteroaryl C3-C8-cycloalkyl or -heterocyclo~alkyl said cycloalkyl or aryl or heteroaryl groups may be fused with cycloalkyl or aryl or heteroaryl groups. R1 is selected from the group consisting of aryl heteroaryl, C3-C8-cycloalkyl or - , heterocyclo-alkyl said (hetero)cycloalkyl or aryl or heteroaryl groups may be fused with …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 27, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 27, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 27, 2003
GrantedNo grant recorded
Term endedMarch 27, 2023
Patent numberCA 2477265 A1
Classification (IPC)C07D417/12 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedMarch 27, 2003Term endedMarch 27, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.